China Antinuclear Antibody Test Market Size & Outlook
China antinuclear antibody test market, 2018-2030 (US$M)
Related Markets
China antinuclear antibody test market highlights
- The China antinuclear antibody test market generated a revenue of USD 38.3 million in 2023 and is expected to reach USD 101.6 million by 2030.
- The China market is expected to grow at a CAGR of 15% from 2024 to 2030.
- In terms of segment, reagents & assay kits was the largest revenue generating product in 2023.
- Reagents & Assay Kits is the most lucrative product segment registering the fastest growth during the forecast period.
Antinuclear antibody test market data book summary
| Market revenue in 2023 | USD 38.3 million |
| Market revenue in 2030 | USD 101.6 million |
| Growth rate | 15% (CAGR from 2023 to 2030) |
| Largest segment | Reagents & assay kits |
| Fastest growing segment | Reagents & Assay Kits |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Assay Kits, Systems, Software & Services |
| Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Immunodiagnostic Systems, Inova Diagnostics, Trinity Biotech PLC ADR, Sebia, Antibodies, Erba Diagnostics, Revvity Inc |
Other key industry trends
- In terms of revenue, China accounted for 2.5% of the global antinuclear antibody test market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan antinuclear antibody test market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 101.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antinuclear Antibody Test Market Scope
Antinuclear Antibody Test Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China antinuclear antibody test market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antinuclear antibody test market will help companies and investors design strategic landscapes.
Reagents & assay kits was the largest segment with a revenue share of 47.26% in 2023. Horizon Databook has segmented the China antinuclear antibody test market based on reagents & assay kits, systems, software & services covering the revenue growth of each sub-segment from 2018 to 2030.
- China Antinuclear Antibody Test Product Outlook (Revenue, USD Million, 2018-2030)
- Reagents & Assay Kits
- Systems
- Software & Services
- China Antinuclear Antibody Test Technique Outlook (Revenue, USD Million, 2018-2030)
- ELISA
- Immunofluorescence Assay
- Multiplex Assay
- China Antinuclear Antibody Test Application Outlook (Revenue, USD Million, 2018-2030)
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Sjogren’s Syndrome
- Scleroderma
- Other Diseases
- China Antinuclear Antibody Test End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Clinical Laboratories
- Physician Office Laboratories
- Other End-uses
Reasons to subscribe to China antinuclear antibody test market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China antinuclear antibody test market databook
-
Our clientele includes a mix of antinuclear antibody test market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China antinuclear antibody test market, including forecasts for subscribers. This country databook contains high-level insights into China antinuclear antibody test market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China antinuclear antibody ana test market size, by product, 2018-2030 (US$M)
China Antinuclear Antibody Test Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
